Thursday, November 21, 2013
This week in techniques
Publication and contact
A vaccine based on a
stabilized variant of respiratory syncytial virus (RSV) F protein
A stabilized variant of RSV F
protein could be used as a vaccine antigen to prevent RSV
infection. RSV F was modified with C-terminal trimerization domains, cysteine
pairs and cavity-filling hydrophobic substitutions to generate stable RSV F
trimers that resembled a conformation of the protein adopted before
virus-cell interaction. In mice, vaccination with modified RSV F provided
neutralizing activity eight times greater than that achieved with vaccination
using an RSV F antigen that adopted a conformation seen after virus-cell
fusion. In rhesus macaques, vaccination with the modified RSV F provided
neutralizing activity 70-80 times greater than that seen with vaccination
using the postfusion-like RSV F.
Next steps include moving the modified version of RSV F into GMP production
for clinical trials.
At least nine companies have therapeutics or vaccines in development to treat
Published online Nov. 21, 2013
RSV F glycoproteins as vaccine antigens are patented; available for licensing
through the NIH's
Office of the Director
McLellan, J.S. et al.
published online Nov. 1, 2013;
Contact: Peter D. Kwong, National Institutes of Health, Bethesda,
Contact: Barney S. Graham,
same affiliation as above
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]